Source comparison
BPC-157 for Post Knee Replacement Research: Protocol Comparison
Primary target Pain reduction, inflammation suppression Collagen architecture, vascular density NSAIDs block prostaglandin synthesis; BPC-157 upregulates VEGF and modulates TGF-β ratios Intervention timing Continuous from day 0 Days 0–21 (proliferative phase)
This comparison does not assign a generated winner or score.
- Primary target
- Pain reduction, inflammation suppression
- Collagen architecture, vascular density
- NSAIDs block prostaglandin synthesis; BPC-157 upregulates VEGF and modulates TGF-β ratios
- Intervention timing
- Continuous from day 0
- Days 0–21 (proliferative phase)
- Standard care is reactive; peptide protocols target specific repair windows
- ROM improvement mechanism
- Mechanical stretch (PT, CPM)
- Enhanced angiogenesis + reduced adhesions
- PT addresses existing tissue; BPC-157 influences tissue formation
- Adhesion prevention
- Passive motion devices
- TGF-β modulation + increased type III collagen
- Mechanical vs biochemical intervention
- Evidence base
- Extensive RCTs in humans
- Preclinical animal models only
- Clinical translation remains investigational